Edition:
United States

Microbix Biosystems Inc (MBX.TO)

MBX.TO on Toronto Stock Exchange

0.37CAD
--
Change (% chg)

-- (--)
Prev Close
$0.37
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
62,888
52-wk High
$0.40
52-wk Low
$0.18

Latest Key Developments (Source: Significant Developments)

Microbix Biosystems applies to TSX to amend terms of 1.5 mln common share purchase warrants
Thursday, 24 Aug 2017 08:30am EDT 

Aug 24 (Reuters) - Microbix Biosystems Inc ::Microbix Biosystems Inc- applied to TSX to amend terms of 1,500,000 common share purchase warrants.Microbix Biosystems Inc - Microbix has applied to TSX to amend exercise price of warrants to $0.32, and to extend their term to August 21, 2021.  Full Article

Microbix Biosystems Q3 revenue C$2.773 million
Monday, 14 Aug 2017 07:00am EDT 

Aug 14 (Reuters) - Microbix Biosystems Inc :Microbix reports record third quarter & nine month sales.Q3 revenue rose 23 percent to C$2.773 million.Qtrly earnings per share ‍$0.002​.Microbix Biosystems - ‍ongoing litigation between major participants in animal genetics industry slowed progress of partnering discussions relating to asset​.  Full Article

Microbix announces expanded customer supply agreement
Tuesday, 8 Aug 2017 08:00am EDT 

Aug 8 (Reuters) - Microbix Biosystems Inc :Sales from agreement are expected to total $25 million, with approximately $10 million being new business​.Agreement to supply existing long-term customer with increasing quantity of Microbix' viral antigen products over next 5 yrs.Parties have option to extend term of supply agreement​.  Full Article

Microbix Biosystems names Cameron Groome CEO
Monday, 24 Jul 2017 08:59am EDT 

July 24 (Reuters) - Microbix Biosystems Inc :Microbix announces leadership transition.Cameron Groome appointed CEO.Microbix Biosystems Inc - ‍Vaughn Embro-Pantalony is retiring as its president and CEO, but remaining an executive director​.  Full Article

Microbix Biosystems Q2 revenue c$2.647 million
Monday, 15 May 2017 08:30am EDT 

May 15 (Reuters) - Microbix Biosystems Inc :Microbix reports strong first half sales growth.Q2 revenue c$2.647 million.  Full Article

Microbix reports Q2 revenue of C$2.647 mln
Monday, 15 May 2017 08:30am EDT 

May 15 (Reuters) - Microbix Biosystems Inc :Microbix reports strong first half sales growth.Q2 revenue C$2.647 million.Microbix Biosystems- expect to see continued growth in second half of fiscal year and for Microbix to potentially achieve record revenues in FY 2017.  Full Article

Microbix Biosystems says consulted with FDA to return its thrombolytic biologic drug to U.S. market
Monday, 1 May 2017 08:00am EDT 

May 1 (Reuters) - Microbix Biosystems Inc :Microbix Biosystems Inc - consulted with FDA regarding plans to return its thrombolytic biologic drug, kinlytic urokinase to U.S. market.Microbix Biosystems Inc - already received expressions of interest to license or acquire kinlytic and to provide full funding for its re-launch program.  Full Article

Microbix Qtrly earnings per share $0.010
Friday, 23 Dec 2016 08:00am EST 

Microbix Biosystems Inc : Qtrly earnings per share $ 0.010 . Microbix reports fiscal 2016 results continued profitability and strong revenue growth .Q4 revenue C$3.471 million versus C$2.114 million.  Full Article

Microbix Q4 earnings per share $0.010
Friday, 23 Dec 2016 08:00am EST 

Microbix Biosystems Inc : Qtrly earnings per share $0.010 . Microbix Biosystems Inc - continuing development of its new molecular controls product line, expects to launch new product offering later in 2017 . Microbix reports fiscal 2016 results continued profitability and strong revenue growth .Q4 revenue C$3.471 million versus C$2.114 million.  Full Article

Microbix Biosystems's CFO Charles Wallace to retire
Tuesday, 1 Nov 2016 08:30am EDT 

Microbix Biosystems Inc : Microbix appoints new chief financial officer . Microbix Biosystems Inc says Jim Currie is joining company on November 1, 2016 as newly appointed chief financial officer .Microbix Biosystems Inc says Charles Wallace, company's chief financial officer, is retiring on December 31, 2016.  Full Article

BRIEF-Microbix Biosystems applies to TSX to amend terms of 1.5 mln common share purchase warrants

* Microbix Biosystems Inc- applied to TSX to amend terms of 1,500,000 common share purchase warrants

No consensus analysis data available.